Accessibility: Skip TopNav
Table
Akari Therapeutics Announces Positive Interim Data from Phase III Paroxysmal Nocturnal Hemoglobinuria (PNH) Study
Format
PNG
Source
Akari Therapeutics Plc
Downloads
Original
Large
Medium
Small